世界の心臓バイオマーカー市場は、2022年に約160億5,000万米ドルと評価され、2023年から2030年の予測期間にわたって14.6％を超える健全な成長率で成長すると予想されています。
心臓バイオマーカーは、心臓の損傷やストレスに反応して血流に放出される分子です。これらのバイオマーカーの評価は、心臓への血液供給不足を特徴とする急性冠症候群（ACS）や心虚血などの状態を診断する際の貴重なツールです。さらに、心臓バイオマーカーの検査は、これらの状態を発症する個人のリスクを評価するのに役立ち、ACS および心臓虚血が疑われる個人のモニタリングと管理に役立ちます。高齢化人口の増加に加え、迅速診断検査の需要の高まり、心臓の健康を促進する取り組みの増加、CVDの定期的なスクリーニングが、世界中で心臓バイオマーカーの需要を促進している主な要因です。
心臓発作や心不全を含むCVDの世界的な有病率は増加しており、診断とモニタリングに役立つ心臓バイオマーカー検査の需要が高まっています。世界保健機関 (WHO) によると、心血管疾患（CVD）は世界中で主な死因として記録されており、年間 1,790 万人が命を落としていると推定されています。さらに、心臓発作と脳卒中は、これらの心血管疾患による死亡の 85% を占めています。また、2020年7月にCureus Journal of Medical Scienceに掲載された論文によると、虚血性心疾患（IHD）は世界的に重要な死因となっています。世界中で約 1 億 2,600 万人（10 万人あたり 1,655 人）、または世界人口の約 1.72% が虚血性心疾患に苦しんでいます。2030年までに、世界中で10万人当たり虚血性心疾患の症例数が1,845人を超えると予想されています。その結果、CVDの発生率の増加が、推定期間中の心臓バイオマーカー市場の成長を推進しています。さらに、ポイントオブケア（POC）心臓診断の需要の急増と迅速な診断検査の需要の高まりにより、予測される数年間にさまざまな収益機会がもたらされます。ただし、心臓バイオマーカー検査に関連する複雑さと厳格な規制の枠組みにより、2023年から2030年の予測期間を通じて市場の成長が妨げられています。
世界の心臓バイオマーカー市場の調査で検討されている主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、確立された医療システムの存在と、さまざまな病状の診断および予測ツールとして心臓バイオマーカーが広く採用されたことにより、2022 年の市場を独占しました。高齢者人口の増加は、急性心筋梗塞などの症状を検出するためにバイオマーカー検査を必要とすることが多く、これらの検査製品の需要の原動力となっています。さらに、この地域におけるQuidel Corporation社やDanaher Corporation社などの主要な業界プレーヤーの存在は、市場の成長にさらに貢献する要因です。一方、アジア太平洋地域は、予測年間で最も高い CAGR で成長すると予想されます。高度な心臓検査へのアクセスの向上、継続的な近代化の取り組み、可処分所得の増加が重要な要因となっています。さらに、この地域における心血管疾患（CVD）の有病率の増加により、強化された診断ツールの必要性が高まっています。対象を絞った疾患研究に対する政府の資金提供や医療支出の増加も重要な役割を果たしています。他の発展途上国と比較すると、インドはCVDの発生率が際立っています。心臓バイオマーカー診断は心血管疾患の診断、評価、治療を可能にする上で極めて重要な役割を果たすため、この多大な疾患負担により心臓バイオマーカー診断の需要が高まることが予想されます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cardiac Biomarkers Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cardiac Biomarkers Market, by Type, 2020-2030 (USD Billion)
1.2.3. Cardiac Biomarkers Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cardiac Biomarkers Market, by End use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Biomarkers Market Dynamics
3.1. Cardiac Biomarkers Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for rapid diagnostic tests
3.1.1.2. Rise in incidences of cardiovascular diseases (CVDs)
3.1.2. Market Challenges
3.1.2.1. Complexities associated with cardiac biomarkers tests
3.1.2.2. Stringent regulatory frameworks
3.1.3. Market Opportunities
3.1.3.1. Surge in demand for Point-of-Care (POC) cardiac diagnostics
3.1.3.2. Growing demand for rapid diagnostic tests
Chapter 4. Global Cardiac Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Biomarkers Market, by Type
5.1. Market Snapshot
5.2. Global Cardiac Biomarkers Market by Type, Performance - Potential Analysis
5.3. Global Cardiac Biomarkers Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Cardiac Biomarkers Market, Sub Segment Analysis
5.4.1. Troponin
5.4.2. CK-MB
5.4.3. Myoglobin
5.4.4. BNP and NT-proBNP
5.4.5. Others
Chapter 6. Global Cardiac Biomarkers Market, by Application
6.1. Market Snapshot
6.2. Global Cardiac Biomarkers Market by Application, Performance - Potential Analysis
6.3. Global Cardiac Biomarkers Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cardiac Biomarkers Market, Sub Segment Analysis
6.4.1. Acute Coronary Syndrome
6.4.2. Myocardial Infarction
6.4.3. Congestive Heart Failure
6.4.4. Others
Chapter 7. Global Cardiac Biomarkers Market, by End use
7.1. Market Snapshot
7.2. Global Cardiac Biomarkers Market by End use, Performance - Potential Analysis
7.3. Global Cardiac Biomarkers Market Estimates & Forecasts by End use 2020-2030 (USD Billion)
7.4. Cardiac Biomarkers Market, Sub Segment Analysis
7.4.1. Laboratory Testing
7.4.2. Point of Care Testing
Chapter 8. Global Cardiac Biomarkers Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cardiac Biomarkers Market, Regional Market Snapshot
8.4. North America Cardiac Biomarkers Market
8.4.1. U.S. Cardiac Biomarkers Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cardiac Biomarkers Market
8.5. Europe Cardiac Biomarkers Market Snapshot
8.5.1. U.K. Cardiac Biomarkers Market
8.5.2. Germany Cardiac Biomarkers Market
8.5.3. France Cardiac Biomarkers Market
8.5.4. Spain Cardiac Biomarkers Market
8.5.5. Italy Cardiac Biomarkers Market
8.5.6. Rest of Europe Cardiac Biomarkers Market
8.6. Asia-Pacific Cardiac Biomarkers Market Snapshot
8.6.1. China Cardiac Biomarkers Market
8.6.2. India Cardiac Biomarkers Market
8.6.3. Japan Cardiac Biomarkers Market
8.6.4. Australia Cardiac Biomarkers Market
8.6.5. South Korea Cardiac Biomarkers Market
8.6.6. Rest of Asia Pacific Cardiac Biomarkers Market
8.7. Latin America Cardiac Biomarkers Market Snapshot
8.7.1. Brazil Cardiac Biomarkers Market
8.7.2. Mexico Cardiac Biomarkers Market
8.8. Middle East & Africa Cardiac Biomarkers Market
8.8.1. Saudi Arabia Cardiac Biomarkers Market
8.8.2. South Africa Cardiac Biomarkers Market
8.8.3. Rest of Middle East & Africa Cardiac Biomarkers Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Quidel Corporation
9.3.3. Siemens Healthcare GmbH
9.3.4. F. Hoffmann-La Roche Ltd.
9.3.5. Danaher Corporation
9.3.6. BIOMÉRIEUX
9.3.7. Bio-Rad Laboratories, Inc.
9.3.8. Randox Laboratories Ltd.
9.3.9. Creative Diagnostics
9.3.10. Life Diagnostics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Cardiac Biomarkers Market, report scope
TABLE 2. Global Cardiac Biomarkers Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Cardiac Biomarkers Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Cardiac Biomarkers Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Cardiac Biomarkers Market estimates & forecasts by End use 2020-2030 (USD Billion)
TABLE 6. Global Cardiac Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Cardiac Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Cardiac Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Cardiac Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Cardiac Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Cardiac Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Cardiac Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Cardiac Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Cardiac Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Cardiac Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Cardiac Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Cardiac Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Cardiac Biomarkers Market
TABLE 71. List of primary sources, used in the study of global Cardiac Biomarkers Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Cardiac Biomarkers Market, research methodology
FIG 2. Global Cardiac Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cardiac Biomarkers Market, key trends 2022
FIG 5. Global Cardiac Biomarkers Market, growth prospects 2023-2030
FIG 6. Global Cardiac Biomarkers Market, porters 5 force model
FIG 7. Global Cardiac Biomarkers Market, pest analysis
FIG 8. Global Cardiac Biomarkers Market, value chain analysis
FIG 9. Global Cardiac Biomarkers Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Cardiac Biomarkers Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Cardiac Biomarkers Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Cardiac Biomarkers Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Cardiac Biomarkers Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Cardiac Biomarkers Market, regional snapshot 2020 & 2030
FIG 15. North America Cardiac Biomarkers Market 2020 & 2030 (USD Billion)
FIG 16. Europe Cardiac Biomarkers Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Cardiac Biomarkers Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Cardiac Biomarkers Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Cardiac Biomarkers Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
